| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2717780 | The American Journal of Medicine | 2006 | 7 Pages |
Abstract
In subjects of normal weight with type 2 diabetes, baseline IGF-II concentration is inversely related to future weight gain, independent of treatment effect, strengthening the putative role for IGF-II in regulating fat mass. We propose that IGF-II measurement has potential utility in this group for targeting such individuals for early intervention.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Adrian H. DM, Lars MD, Simon G. PhD, Julie BSc, Anne BSc, Louise BSc, Valdemar MD, J. Kennedy MD, Anne PhD, J. Martin MD, Kerstin MD,